Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,575
Closed -$63.9K 439
2023
Q1
$63.9K Sell
8,575
-3,295
-28% -$33K 0.04% 418
2022
Q4
$147K Buy
11,870
+7,269
+158% +$128K 0.08% 349
2022
Q3
$95K Buy
4,601
+33
+0.7% +$917 0.04% 422
2022
Q2
$127K Buy
4,568
+1,681
+58% +$57.5K 0.05% 361
2022
Q1
$126K Sell
2,887
-172
-6% -$7.48K 0.06% 253
2021
Q4
$169K Buy
3,059
+517
+20% +$31.9K 0.06% 288
2021
Q3
$157K Sell
2,542
-134
-5% -$8.82K 0.07% 330
2021
Q2
$227K Sell
2,676
-1,595
-37% -$146K 0.09% 254
2021
Q1
$338K Buy
4,271
+74
+2% +$4.8K 0.14% 215
2020
Q4
$244K Buy
+4,197
New +$198K 0.1% 318

Other funds holding AFMD

Virtus ETF Advisers's AFMD Position: Q2 2023 in Review

Virtus ETF Advisers sold out of Affimed (AFMD) in Q2 2023, closing a stake of 8,575 shares — an estimated $63.9K sold.

Virtus ETF Advisers first reported a position in AFMD in Q4 2020 and held it in 10 quarters. The position peaked at $338K in Q1 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • Virtus ETF Advisers reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 8,575 Affimed shares in Q2 2023, an estimated $63.9K.
  • Virtus ETF Advisers first reported a position in Affimed in Q4 2020 and held it in 10 quarters.
  • Virtus ETF Advisers's Affimed position peaked at $338K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.